KEMPHARM INC (KMPH)

US4884452065 - Common Stock

5.81  -0.02 (-0.34%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
10.72M28.65M13.29M12.84M0.00
Operating Expenses
29.15M20.92M18.49M33.18M55.50M
Research and Development
16.07M10.16M8.84M19.42M41.76M
Selling, General, and Administrative Expenses
12.82M8.70M8.34M10.82M13.74M
Operating Income
-18.43M7.73M-5.20M-20.34M-55.50M
Interest Income/Expense
151.00K-154.00K-7.19M-4.21M-690.00K
Non Recurring Items
-17.66M-16.10M-410.00K0.00-400.00K
Income Before Taxes
-35.94M-8.52M-12.79M-24.54M-56.59M
Income Tax
-718.00K34.00K-30.00K-20.00K-130.00K
Net Income
-35.23M-62.90M-12.76M-24.52M-56.47M
EBITDA
-17.72M7.99M-4.93M-20.04M-55.18M
 
Per Share Data
EPS Diluted Total Ops
-1.02-2.11-3.21-13.25-50.41
Non GAAP EPS
-0.51-0.46-3.31-11.84-61.12
 
Statistics
Profit Margin
-328.56%-219.54%-96.01%-190.97%N/A
Operating Profit Margin
-171.91%26.98%-39.13%-158.41%N/A

All data in USD

Charts